Arkis CerebroFlo EVD Drainage Catheter for Cerebrospinal Fluid Cleared by FDA

September 20th, 2017 Editors Neurology, Neurosurgery

Arkis BioSciences, a young medical technology company out of Knoxville, Tennessee, won FDA clearance for its CerebroFlo external ventricular drainage catheter. The device indicated for positioning within the ventricular cavity of the brain and establishing a drainage channel to release cerebrospinal fluid.

The company touts the use of Endexo, a coating material from Interface Biologics (Toronto, Canada), on the surface of the new catheter. It stops platelet activation and reduces coagulation activity in its vicinity, helping to prevent infections, occlusions, and other potential problems, which the firm says is backed up by clinical studies in other catheters using Endexo.

“Arkis’ in vitro studies have shown 99% less biomatter accumulation onto CerebroFlo’s catheter surfaces, which may reduce fouling,” said Seaver. “Further in vitro studies are underway to characterize CerebroFlo’s ability to prevent infectious biofilm formations without the use of eluting antibiotic drugs.”

Product page: CerebroFlo EVD Catheter…

Via: Arkis…

Upcoming conferences

october

18octallday19alldayWorld Congress on Polycystic Ovarian Syndrome and Fertility, 2018Abu Dhabi, UAE

18octallday19alldayManaging Your Complaints and Obstacles in Post-Market Requirements -- Results from Top Medical Device Observations During an InspectionMinneapolis, MN, USA

Event Details

Post-Market activities, Complaint Handling, MDRs, and Recalls are expensive, time consuming, and often lead to more serious financial consequences. Over 80% of FDA Inspection target observations for lack of compliance in these areas.

By attending this seminar, you will discover:

How to overcome one of the biggest obstacles device manufacturers face
How the FDA expects you to develop and implement proper handling of complaints reportable or non-reportable, product complaint handling and documentation
How and when to file Medical Device Reports (MDR), effective and appropriate communication with the appropriate regulatory agencies in the event of a recall.
How to conduct a correction and removal actions to avoid a recall crisis, including required recordkeeping, expectation from FDA and other regulatory agencies in the event of a recall and key factors in implementing and maintaining compliance with the regulations and real life experiences of FDA.

**New course materials have been added, updated content will include:

Creating Standard Operating Systems (SOPs) for Post-Market Quality Systems and
What to expect from the changes in ORA with Inspection Structure Realignment

This Seminar will have you stop spinning your wheels with nonessential activities, and leave you with a comprehensive learning package that only Rita Hoffman, a former FDA CDRH Recall Branch Chief with experience across the device, drug and veterinary industries can provide.

Spend one and a half days in an interactive course led by Ms. Rita Hoffman, Former FDA CDRH Recall Branch Chief with over 36 years with FDA and leading Industry Expert, who will provide the participants with tools to minimize risk of regulatory enforcement actions.

Time

october 18 (Thursday) - 19 (Friday)

Organizer

Compliance Online 80068SEM

Learn More

Calendar GoogleCal

18octallday19allday18th Global Ophthalmology, Optometry and Glaucoma Conference, 2018Helsinki, Finland

18octallday19alldayBiology and Pathology of Infectious Disease Conference, 2018Helsinki, Finland

18octallday19allday14th Global Biomarkers Summit, 2018Amsterdam, Netherlands

22octallday23alldayInternational Conference on Breast Cancer, 2013Vancouver, British Columbia, Canada